This inventor holds 1 USPTO granted patent. Top assignee: Siemens Healthcare Diagnostics Gmbh. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Martin Fletcher - Innovator in Chemiluminescent Immunoassay Testing
Introduction
Martin Fletcher is an accomplished inventor based in Hopewell Junction, NY (US). He has made significant contributions to the field of chemiluminescent immunoassay testing. His innovative approach has led to the development of a unique system that enhances the accuracy and efficiency of immunoassay procedures.
Latest Patents
Fletcher holds a patent for a "System, device and method for reducing luminescence output shifts." This invention focuses on devices, systems, and methods for conducting chemiluminescent immunoassay testing. It specifically addresses the initiation and monitoring of chemiluminescent reactions in multiple assays simultaneously. The patent also introduces a base reagent injector assembly with an 'e-channel' that creates swirling turbulence in the base reagent before it is introduced into the cuvette. This innovation effectively mitigates the 'RLU shift' phenomenon, which can cause fluctuations in luminescence output between assays. He has 1 patent to his name.
Career Highlights
Martin Fletcher is currently employed at Siemens Healthcare Diagnostics GmbH, where he continues to work on advancing diagnostic technologies. His expertise in chemiluminescent reactions has positioned him as a key player in the development of innovative healthcare solutions.
Collaborations
Fletcher collaborates with William Carpenter, leveraging their combined expertise to enhance the capabilities of their projects. Their teamwork has been instrumental in driving forward the advancements in immunoassay testing.
Conclusion
Martin Fletcher's contributions to the field of chemiluminescent immunoassay testing exemplify the impact of innovation in healthcare diagnostics. His patented technology not only improves testing accuracy but also streamlines the overall process.